Schering - PDFSEARCH.IO - Document Search Engine

Schering
Results: 483

#	Item
151	Bulletin # 892 September 30, 2014 NB Drug Plans Formulary Update Please find attached a list of generic drug product additions to the New Brunswick Drug Plans Add to Reading List Source URL: www2.gnb.ca Language: English - Date: 2014-10-01 10:33:05 Eli Lilly and Company Medicine Merck Schering-Plough Ezetimibe Lactams Mylan Statin Vancomycin Chemistry Organic chemistry Organofluorides
152	FOX ROTHSCHILD, LLP Midtown Building, 4th floor 1301 Atlantic Avenue Atlantic City, New Jersey 0840 I Telephone: [removed]Attorneys for Defendant, Merck Sharp & Dohme, Corp. Add to Reading List Source URL: www.judiciary.state.nj.us Language: English - Date: 2014-10-24 13:55:56 Schering-Plough Sanders Vien Pharmaceutical industry Merck Dow Jones Industrial Average Merck & Co. Readington New Jersey
153	Safety Page Fatal medication errors associated with Temodar emodar (temozolomide capsules), manufactured by Schering, was approved on Aug. 11, 1999, under NDA[removed], for the treatment of adult patients with refractory a Add to Reading List Source URL: www.fda.gov Language: English Prodrugs Amides Lactams Schering-Plough Temozolomide Morphinans Chemistry Organic chemistry Pharmacology
154	Treating Allergies, Hay Fever, and Hives: Comparing Effectiveness, Safety, and Price There are newer antihistamines. Antihistamines are drugs that can relieve the symptoms Add to Reading List Source URL: www.consumerreports.org Language: English Ethers Piperidines Carboxylic acids Schering-Plough Desloratadine Loratadine Levocetirizine Histamine antagonist Cetirizine Chemistry Organic chemistry Organochlorides
155	BUILDING TRUST IN CANADIAN BEEF Needle free injections show promise Manitoba research gives fresh look at intriguing technology When researchers study emerging technology they want to Add to Reading List Source URL: www.verifiedbeef.org Language: English - Date: 2014-08-27 15:09:10 Merck Vaccination Dow Jones Industrial Average Merck & Co. Readington New Jersey Schering-Plough Injection Vaccine Pen needles Pharmacology Pharmaceutical sciences Prevention
156	Microsoft Word - DUR Committee Oct Agenda2.doc Add to Reading List Source URL: www.mainecarepdl.org Language: English - Date: 2014-10-08 09:02:37 Combination drugs Nootropics Schering-Plough Merck Organofluorides Dexmethylphenidate Sitagliptin/metformin Certolizumab pegol Niacin/simvastatin Pharmacology Chemistry Medicine
157	Actions Taken by FDA Center for Veterinary Medicine The following corrections or additions to the list were published in the Federal Register in December[removed]Original Approvals This section displays the original approv Add to Reading List Source URL: www.fda.gov Language: English Medicine Mycoplasma gallisepticum Tylosin Food and Drug Administration Mycoplasma Methadone Schering-Plough Federal Register Biology Bacteria Microbiology
158	Market Development Approaches Working Group Minutes of Teleconference, 2 July 2009 Add to Reading List Source URL: www.rhsupplies.org Language: English - Date: 2009-09-17 16:50:42 Market segmentation Economy of Germany Germany Schering AG Schering Teleconference
159	IMI 1ST CALL PROJECTS: SAFETY SAFE-T SAFER AND FASTER EVIDENCE-BASED TRANSLATION SUMMARY: Add to Reading List Source URL: www.imi.europa.eu Language: English - Date: 2011-04-01 08:57:16 Pharmacology European Federation of Pharmaceutical Industries and Associations Novartis Boehringer Ingelheim Bayer Schering Pharma Innovative Medicines Initiative Biomarker Sanofi Bayer Medicine Pharmaceutical industry Pharmaceutical sciences
160	IMI 1ST CALL PROJECTS: EFFICACY SAFESCIMET EUROPEAN MODULAR EDUCATION AND TRAINING PROGRAMME IN SAFETY SCIENCES FOR MEDICINES SUMMARY: Add to Reading List Source URL: www.imi.europa.eu Language: English - Date: 2011-04-01 06:44:54 Pharmacy European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative Boehringer Ingelheim Bayer Schering Pharma Novartis Hoffmann-La Roche Uppsala University Sanofi Pharmaceutical sciences Pharmacology Pharmaceutical industry

UPDATE